In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae

Ceftazidime/avibactam is an important treatment option for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-Kp), however, resistance can emerge during treatment. The objective of the study was to define the ceftazidime/avibactam concentrations required to suppres...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yanqin, Wu, Tiffany, Perez, Omar, Rana, Amisha P., Chen, Liang, Kreiswirth, Barry N., Satlin, Michael J., Bulman, Zackery P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982837/
https://www.ncbi.nlm.nih.gov/pubmed/33763041
http://dx.doi.org/10.3389/fmicb.2021.618087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982837/
https://www.ncbi.nlm.nih.gov/pubmed/33763041
http://dx.doi.org/10.3389/fmicb.2021.618087

Ejemplares similares